Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1544-1550

  Zu, Yun Fen ^a   Wang, Xi Cai ^b   Chen, Yan ^b   Wang, Ji Ying ^a   Liu, Xin ^b   Li, Xin ^a   Li, Cheng Wen ^b   Xie, Yu Cheng ^a   Luo, Yan ^a   Shang, Xie Qin ^a   Guo, Jing ^a  

^a Second People's Hospital of Yunnan Province   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Ki 67; Non small cell lung cancer lines; Thyroid transcription factor 1; Xuanwei lung adenocarcinoma

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; THYROID TRANSCRIPTION FACTOR 1;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; THYROID TRANSCRIPTION FACTOR 1 GENE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; HUMANS; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866436196     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2009     Document Type: Article

References (24)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Yao H, Zhang Z, Xiao Z, et al: Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 65: 41-48, 2009.
3. Hanagiri T, Baba T, So T, et al: Time trends of surgical outcome in patients with non-small cell lung cancer. J Thorac Oncol 5: 825-829, 2010.
4. Kim KY, Ahn JH and Cheon HG: Apoptotic action of peroxisome proliferator-activated receptor-ã activation in human non-small cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Mol Pharmacol 72: 674-685, 2007.
5. Lazzaro D, Price M, de Felice M and Di Lauro R: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of foetal brain. Development 113: 1093-1104, 1991.
6. Ikeda K, Clark JC, Shaw-White JR, Stahlman MT, Boutell CJ and Whitset JA: Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J Biol Chem 270: 8108-8114, 1995.
7. Maeda Y, Hunter TC, Loudy DE, Davé V, Schreiber V and Whitsitt JA: PARP-2 interacts with TTF-1 and regulates expression of surfactant protein-B. J Biol Chem 28: 9600-9606, 2006. (Pubitemid 43864678)
8. Zhou H, Morotti RA, Profitt SA, Langston C, Wert SE, Whitsett JA and Greco MA: Expression of thyroid transcription factor-1, surfactant proteins, type I cell-associated antigen, and Clara cell secretory protein in pulmonary hypoplasia. Pediatr Dev Pathol 4: 364-371, 2001. (Pubitemid 32703029)
9. Zamecnik J and Kodet R: Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch 440: 353-361, 2002. (Pubitemid 34328065)
10. Pelosi G, Fraggeta F, Pasini F, et al: Immunoreactivity for thyroid transcription factor-1 in stage I non-small carcinomas of the lung. Am J Surg Pathol 25: 363-372, 2001. (Pubitemid 32175139)
11. Kaufmann O and Dietel M: Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology 36: 8-16, 2000. (Pubitemid 30055417)
12. Berghmans T, Paesmans M, Mascaux C, et al: Thyroid transcription factor 1 - a new prognostic factor in lung cancer: a meta-analysis. Ann Oncol 17: 1673-1676, 2006. (Pubitemid 44680888)
13. Myong NH: Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with expressions of p53 and Ki-67 proteins. J Korean Med Sci 18: 494-500, 2003.
14. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
15. Fujita J, Ohtsuki Y, Bandoh S, et al: Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines. Lung Cancer 39: 31-36, 2003. (Pubitemid 36020292)
16. Zhang P, Zuo H, Nakamura Y, Nakamura M, Wakasa T and Kakudo K: Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol Int 56: 240-245, 2006.
17. van der Kallen CJ, Spierings DC, Thijssen JH, Blankenstein MA and de Bruin TW: Disrupted co-ordination of Pax8 and thyroid transcription factor-1 gene expression in a dedifferentiated rat thyroid tumor cell line derived from FRTL-5. J Endocrinol 150: 377-382, 1996. (Pubitemid 26319833)
18. Puppin C, D'Elia AV, Pellizzari L, et al: Thyroid-specific transcription factors control Hex promoter activity. Nucleic Acids Res 31: 1845-1852, 2003. (Pubitemid 36432691)
19. Ndoye A, Merlin JL, Leroux A, et al: Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes. J Gene Med 6: 884-894, 2004. (Pubitemid 40228104)
20. Pataer A, Fanale MA, Roth JA, Swisher SG and Hunt KK: Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Cancer Gene Ther 13: 806-814, 2006. (Pubitemid 44100494)
21. Fukazawa T, Maeda Y, Durbin ML, et al: Pulmonary adenocarcinoma-targeted gene therapy by a cancer- and tissue-specific promoter system. Mol Cancer Ther 6: 244-252, 2007. (Pubitemid 46206688)
22. Weir BA, Woo MS, Getz G, et al: Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898, 2007. (Pubitemid 350231325)
23. Yatabe Y, Mitsudomi T and Takahashi T: TTF-1 expression in pulmonary adenocarcinomas. American J Surg Pathol 26: 767-773, 2002. (Pubitemid 34546942)
24. Winslow MM, Dayton TL, Verhaak RG, et al: Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 473: 101-104, 2011.